JANUET 50/850 MG TABLETS

Country: Իսրայել

language: անգլերեն

source: Ministry of Health

active_ingredient:

METFORMIN HYDROCHLORIDE 850 MG; SITAGLIPTIN AS MONOHYDRATE PHOSPHATE 50 MG

MAH:

MERCK SHARP & DOHME ISRAEL LTD

ATC_code:

A10BA02

pharmaceutical_form:

TABLETS

administration_route:

PER OS

manufactured_by:

MERCK SHARP & DOHME CORP., USA

therapeutic_group:

METFORMIN

therapeutic_indication:

Januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. Important limitations of use:Januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.Januet has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Januet.

authorization_date:

2009-01-01